Mancini Marianna's most recent trade in Viking Therapeutics Inc was a trade of 7,667 Common Stock, par value $0.00001 per share done . Disclosure was reported to the exchange on July 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Viking Therapeutics Inc | Mancini Marianna | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2025 | 7,667 | 381,801 (0%) | 0% | 0 | Common Stock, par value $0.00001 per share | |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 27.77 per share. | 02 Jul 2025 | 4,266 | 377,535 (0%) | 0% | 27.8 | 118,473 | Common Stock, par value $0.00001 per share |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 42.69 per share. | 03 Jan 2025 | 49,115 | 379,234 (0%) | 0% | 42.7 | 2,096,685 | Common Stock, par value $0.00001 per share |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 44,533 | 406,682 (0%) | 0% | 0 | Common Stock, par value $0.00001 per share | |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 37,200 | 37,200 | - | - | Stock Option (Right to Buy) | |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 21,667 | 428,349 (0%) | 0% | 0 | Common Stock, par value $0.00001 per share | |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 43.32 per share. | 03 Jan 2025 | 5,100 | 374,134 (0%) | 0% | 43.3 | 220,914 | Common Stock, par value $0.00001 per share |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2024 | 21,667 | 380,175 (0%) | 0% | 0 | Common Stock, par value $0.00001 per share | |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 56.98 per share. | 29 Jul 2024 | 14,704 | 365,471 (0%) | 0% | 57.0 | 837,834 | Common Stock, par value $0.00001 per share |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2024 | 10,000 | 358,508 (0%) | 0% | 0 | Common Stock, par value $0.00001 per share | |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 57.82 per share. | 29 Jul 2024 | 3,322 | 362,149 (0%) | 0% | 57.8 | 192,078 | Common Stock, par value $0.00001 per share |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 79.29 per share. | 01 May 2024 | 119,946 | 354,756 (0%) | 0% | 79.3 | 9,511,058 | Common Stock, par value $0.00001 per share |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 78.65 per share. | 01 May 2024 | 105,343 | 474,702 (0%) | 0% | 78.6 | 8,284,974 | Common Stock, par value $0.00001 per share |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.80 per share. | 01 May 2024 | 90,000 | 543,507 (0%) | 0% | 5.8 | 522,000 | Common Stock, par value $0.00001 per share |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2024 | 90,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.88 per share. | 01 May 2024 | 87,000 | 453,507 (0%) | 0% | 4.9 | 424,560 | Common Stock, par value $0.00001 per share |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2024 | 87,000 | 87,000 | - | - | Stock Option (Right to Buy) | |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2024 | 51,000 | 153,000 | - | - | Stock Option (Right to Buy) | |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.52 per share. | 01 May 2024 | 51,000 | 629,933 (0%) | 0% | 8.5 | 434,520 | Common Stock, par value $0.00001 per share |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.77 per share. | 01 May 2024 | 35,426 | 578,933 (0%) | 0% | 7.8 | 275,260 | Common Stock, par value $0.00001 per share |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2024 | 35,426 | 18,574 | - | - | Stock Option (Right to Buy) | |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 77.49 per share. | 01 May 2024 | 26,142 | 580,045 (0%) | 0% | 77.5 | 2,025,830 | Common Stock, par value $0.00001 per share |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 76.40 per share. | 01 May 2024 | 23,746 | 606,187 (0%) | 0% | 76.4 | 1,814,301 | Common Stock, par value $0.00001 per share |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.68 per share. | 01 May 2024 | 17,999 | 366,507 (0%) | 0% | 4.7 | 84,235 | Common Stock, par value $0.00001 per share |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2024 | 17,999 | 1 | - | - | Stock Option (Right to Buy) | |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 80.08 per share. | 01 May 2024 | 6,248 | 348,508 (0%) | 0% | 80.1 | 500,310 | Common Stock, par value $0.00001 per share |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2024 | 31,667 | 380,175 (0%) | 0% | 0 | Common Stock, par value $0.00001 per share | |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.34 per share. | 27 Mar 2024 | 16,610 | 363,565 (0%) | 0% | 83.3 | 1,384,277 | Common Stock, par value $0.00001 per share |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 31,667 | 365,466 (0%) | 0% | 0 | Common Stock, par value $0.00001 per share | |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.22 per share. | 01 Mar 2024 | 16,958 | 348,508 (0%) | 0% | 85.2 | 1,445,161 | Common Stock, par value $0.00001 per share |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2024 | 155,000 | 155,000 | - | - | Stock Option (Right to Buy) | |
| Viking Therapeutics Inc | Mancini Marianna | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2024 | 70,000 | 380,675 (0%) | 0% | 0 | Common Stock, par value $0.00001 per share | |
| Viking Therapeutics Inc | Mancini Marianna | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.40 per share. | 03 Jan 2024 | 32,677 | 347,998 (0%) | 0% | 17.4 | 568,580 | Common Stock, par value $0.00001 per share |
| Viking Therapeutics Inc | Mancini Marianna | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2024 | 28,334 | 327,208 (0%) | 0% | 0 | Common Stock, par value $0.00001 per share | |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.40 per share. | 03 Jan 2024 | 16,533 | 310,675 (0%) | 0% | 17.4 | 287,674 | Common Stock, par value $0.00001 per share |
| Viking Therapeutics Inc | Mancini Marianna | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.58 per share. | 03 Jan 2024 | 14,199 | 333,799 (0%) | 0% | 18.6 | 263,817 | Common Stock, par value $0.00001 per share |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.07 per share. | 17 Apr 2023 | 12,500 | 300,263 (0%) | 0% | 13.1 | 163,375 | Common Stock, par value $0.00001 per share |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 12,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 17 Apr 2023 | 12,500 | 287,763 (0%) | 0% | 20 | 250,000 | Common Stock, par value $0.00001 per share |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2023 | 56,667 | 318,562 (0%) | 0% | 0 | Common Stock, par value $0.00001 per share | |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.01 per share. | 30 Mar 2023 | 36,100 | 261,895 (0%) | 0% | 17.0 | 614,029 | Common Stock, par value $0.00001 per share |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.57 per share. | 30 Mar 2023 | 30,799 | 287,763 (0%) | 0% | 17.6 | 541,138 | Common Stock, par value $0.00001 per share |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Mar 2023 | 23,100 | 0 | - | - | Stock Option (right to buy) | |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.52 per share. | 30 Mar 2023 | 23,100 | 284,995 (0%) | 0% | 8.5 | 196,812 | Common Stock, par value $0.00001 per share |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Mar 2023 | 10,000 | 0 | - | - | Stock Option (right to buy) | |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.69 per share. | 30 Mar 2023 | 10,000 | 294,995 (0%) | 0% | 7.7 | 76,900 | Common Stock, par value $0.00001 per share |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Mar 2023 | 3,000 | 1,000 | - | - | Stock Option (right to buy) | |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.47 per share. | 30 Mar 2023 | 3,000 | 297,995 (0%) | 0% | 6.5 | 19,410 | Common Stock, par value $0.00001 per share |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 28 Mar 2023 | 196,563 | 288,137 (0%) | 0% | 15 | 2,948,445 | Common Stock, par value $0.00001 per share |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Mar 2023 | 53,054 | 0 | - | - | Stock Option (right to buy) | |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.23 per share. | 28 Mar 2023 | 53,054 | 405,200 (0%) | 0% | 1.2 | 65,256 | Common Stock, par value $0.00001 per share |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 16.00 per share. | 28 Mar 2023 | 41,242 | 261,895 (0%) | 0% | 16 | 659,872 | Common Stock, par value $0.00001 per share |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Mar 2023 | 30,000 | 0 | - | - | Stock Option (right to buy) | |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.37 per share. | 28 Mar 2023 | 30,000 | 484,700 (0%) | 0% | 4.4 | 131,100 | Common Stock, par value $0.00001 per share |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.65 per share. | 28 Mar 2023 | 24,500 | 454,700 (0%) | 0% | 4.7 | 113,925 | Common Stock, par value $0.00001 per share |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Mar 2023 | 24,500 | 0 | - | - | Stock Option (right to buy) | |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Mar 2023 | 15,000 | 0 | - | - | Stock Option (right to buy) | |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Mar 2023 | 15,000 | 0 | - | - | Stock Option (right to buy) | |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Mar 2023 | 15,000 | 0 | - | - | Stock Option (right to buy) | |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Mar 2023 | 15,000 | 0 | - | - | Stock Option (right to buy) | |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.13 per share. | 28 Mar 2023 | 15,000 | 303,137 (0%) | 0% | 9.1 | 136,950 | Common Stock, par value $0.00001 per share |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.08 per share. | 28 Mar 2023 | 15,000 | 420,200 (0%) | 0% | 1.1 | 16,200 | Common Stock, par value $0.00001 per share |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.26 per share. | 28 Mar 2023 | 15,000 | 352,146 (0%) | 0% | 1.3 | 18,900 | Common Stock, par value $0.00001 per share |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.15 per share. | 28 Mar 2023 | 15,000 | 332,273 (0%) | 0% | 2.2 | 32,250 | Common Stock, par value $0.00001 per share |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Mar 2023 | 10,000 | 0 | - | - | Stock Option (right to buy) | |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.04 per share. | 28 Mar 2023 | 10,000 | 430,200 (0%) | 0% | 1.0 | 10,400 | Common Stock, par value $0.00001 per share |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Mar 2023 | 4,873 | 0 | - | - | Stock Option (right to buy) | |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.88 per share. | 28 Mar 2023 | 4,873 | 337,146 (0%) | 0% | 1.9 | 9,161 | Common Stock, par value $0.00001 per share |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.95 per share. | 15 Jan 2023 | 1,079 | 317,273 (0%) | 0% | 8.9 | 9,657 | Common Stock, par value $0.00001 per share |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2022 | 204,000 | 204,000 | - | - | Stock Option (Right to Buy) | |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2022 | 90,667 | 351,200 (0%) | 0% | 0 | Common Stock, par value $0.00001 per share | |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2022 | 23,500 | 273,306 (0%) | 0% | 0 | Common Stock, par value $0.00001 per share | |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.52 per share. | 30 Dec 2022 | 18,854 | 332,346 (0%) | 0% | 8.5 | 160,636 | Common Stock, par value $0.00001 per share |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.42 per share. | 30 Dec 2022 | 13,994 | 318,352 (0%) | 0% | 8.4 | 117,829 | Common Stock, par value $0.00001 per share |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.40 per share. | 30 Dec 2022 | 12,773 | 260,533 (0%) | 0% | 9.4 | 120,066 | Common Stock, par value $0.00001 per share |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 174,000 | 174,000 | - | - | Stock Option (Right to Buy) | |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 77,333 | 251,367 (0%) | 0% | 0 | Common Stock, par value $0.00001 per share | |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.62 per share. | 03 Jan 2022 | 11,845 | 239,522 (0%) | 0% | 4.6 | 54,724 | Common Stock, par value $0.00001 per share |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.88 per share. | 03 Jan 2022 | 3,919 | 174,034 (0%) | 0% | 4.9 | 19,125 | Common Stock, par value $0.00001 per share |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Sep 2021 | 6,667 | 180,374 (0%) | 0% | 0 | Common Stock, par value $0.00001 per share | |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.50 per share. | 28 Sep 2021 | 2,839 | 177,535 (0%) | 0% | 6.5 | 18,454 | Common Stock, par value $0.00001 per share |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.68 per share. | 15 Jan 2021 | 994 | 169,952 (0%) | 0% | 6.7 | 6,640 | Common Stock, par value $0.00001 per share |
| Viking Therapeutics Inc | Marianna Mancini | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.48 per share. | 15 Jan 2021 | 686 | 170,946 (0%) | 0% | 6.5 | 4,445 | Common Stock, par value $0.00001 per share |